Geneva, Switzerland

Matthieu Künzi

This inventor holds 1 USPTO granted patent and 1 EPO patent. Top assignee: Ecole Polytechnique FÉDÉRALE De Lausanne (Epfl). Active years: 2026.


% Patents Active = 100.0


Average Co-Inventor Count = 3.0

ph-index = 1


Company Filing History:


Years Active: 2026

Loading Chart...
Loading Chart...
1 patent (USPTO):Explore Patents

Title: Matthieu Künzi: Innovator in Retinal Imaging Technology

Introduction

Matthieu Künzi is a prominent inventor based in Geneva, Switzerland. He has made significant contributions to the field of retinal imaging technology. His innovative work focuses on enhancing the methods used for eye examinations and diagnostics.

Latest Patents

Künzi holds a patent for a Multi-modal retinal imaging platform. This invention relates to oblique transscleral illumination of an eye fundus with at least one physical point light source around the eye. It allows for dark field imaging combined with optical coherence tomography imaging. This advancement has the potential to improve the accuracy and effectiveness of retinal examinations.

Career Highlights

Matthieu Künzi is affiliated with the École Polytechnique Fédérale de Lausanne (EPFL). His work at this prestigious institution has allowed him to collaborate with leading experts in the field. Künzi's dedication to research and innovation has positioned him as a key figure in the development of advanced imaging technologies.

Collaborations

Künzi has worked alongside notable colleagues such as Timothé Laforest and Christophe Moser. Their collaborative efforts have contributed to the advancement of retinal imaging techniques and have fostered a productive research environment.

Conclusion

Matthieu Künzi's contributions to retinal imaging technology exemplify the impact of innovative thinking in the medical field. His patent and ongoing research continue to pave the way for advancements in eye care and diagnostics.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to [email protected]
Loading…